Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial

Despite not reaching its prespecified enrollment, there was no signal to either benefit or harm high-dose dexamethasone over standard-dose dexamethasone in patients with COVID-19 and moderate-to-severe ARDS. Trial registration Trial registration: ClinicalTrials.gov Identifier: NCT04663555. Registered 10 December 2020, https://clinicaltrials.gov/study/NCT04663555?term=NCT04663555&rank=1 and EudraCT: 2020-005887-70.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2024-12-23
DOI
https://doi.org/10.1186/s40001-024-02215-6
Citations
4
Primary Topic
Respiratory Support and Mechanisms
Type
article
Field-Weighted Citation Impact
1.68

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial

Milan Kratochvíl, Jan Varady, Jiří Pouska, Martin Kolář et al.
4 citations
European journal of medical research
Respiratory Support and Mechanisms
1.68
article

Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial

Milan Kratochvíl, Jan Varady, Jiří Pouska, Martin Kolář, Petr Suk, Tereza Šobáňová, Jan Rulíšek, Marek Fencl, Jana Vinklerová, Mervyn Singer, Michal Otáhal, Adam Svobodník, Václav Zvoníček, Ivan Čundrle, Karolína Grodová, Michal Fric, Martin Kutěj, Tomáš Tyll, Lenka Doubravská, Pavel Suk, Filip Haiduk, Jana Kubátová, Jan Hudec, Jan Maláska, Jozef Klučka, Martin Balík, Jan Máca, Tomáš Graus, Tomáš Gabrhelík, Marcela Káňová, Petr Štourač, Peter Sklienka, Pavel Štětka, Pavel Novotný, Miloš Chobola, Jakub Kletečka, František Duška, P Kafka, Helena Antoni, Radovan Turek, Jan Zatloukal, Tomáš Tencer, Olga Klementová, Jan Stašek, Vladimír Šrámek, Filip Burša, Marek Flaksa, Regina Demlová, Tomáš Korbička, Aleš Rára, Eva Svobodová, Radka Štěpánová, Jan Hruda, Marek Lukeš, Libor Číž
article en
4 citations

Abstract

Despite not reaching its prespecified enrollment, there was no signal to either benefit or harm high-dose dexamethasone over standard-dose dexamethasone in patients with COVID-19 and moderate-to-severe ARDS. Trial registration Trial registration: ClinicalTrials.gov Identifier: NCT04663555. Registered 10 December 2020, https://clinicaltrials.gov/study/NCT04663555?term=NCT04663555&rank=1 and EudraCT: 2020-005887-70.

European journal of medical researchVol. 29(1)
Charles University (CZ), Masaryk University (CZ), Bury College (GB), University Hospital Ostrava (CZ), University Hospital Brno (CZ), University Hospital Olomouc (CZ), Military University Hospital Prague (CZ), St. Anne's University Hospital Brno (CZ), University Hospital Kralovske Vinohrady (CZ), General University Hospital in Prague (CZ), University College London (GB), Palacký University Olomouc (CZ)
Ministerstvo Školství, Mládeže a Tělovýchovy, Všeobecná Fakultní Nemocnice v Praze
Good health and well-being
Openalex Percentile: Top 14%
Respiratory Support and Mechanisms
1.68
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.